RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
Thromb Haemost 1990; 63(01): 146-147
DOI: 10.1055/s-0038-1645707
DOI: 10.1055/s-0038-1645707
Letter to the Editor
Thrombotic Changes in Haemostasis Following Intravenous Streptokinase Treatment for Acute Myocardial Infarction
Weitere Informationen
Publikationsverlauf
Received 23. August 1989
Accepted 27. Oktober 1989
Publikationsdatum:
02. Juli 2018 (online)
-
References
- 1 Simoons ML. Thrombolytic therapy in acute myocardial infarction. Ann Rev Med 1989; 40: 181-187
- 2 Bates ER, Topol EJ. Thrombolytic therapy for acute myocardial infarction. Chest 1989; (Suppl. 95) 257-263
- 3 Jusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease. I Treatment following myocardial infarction. J Am Med Assoc 1988; 260: 2089-2093
- 4 Naylor CD, Armstrong PW. Guidelines for the use of intravenous thrombolytic agents in acute myocardial infarction. Can Med Assoc J 1989; 140: 1289-1299
- 5 Hogg KJ. ECG evidence of myocardial salvage after thrombolysis in acute myocardial infarction. Br Heart J 1989; 61: 489-493
- 6 Rapaport SI. A plasma protein C activity assay suitable for clinical laboratory. Am J Clin Pathol 1989; 87: 491-497
- 7 Zimmerman TS. Determination of the von Willebrand’s disease antigen in plasma by quantitative immunoelectrophoresis. J Lab Clin Med 1975; 86: 152-159
- 8 Fitzgerald DJ, Wright F, FitzGerald GA. Increased thromboxane biosynthesis during coronary thrombolysis. Evidence that platelet activation and thromboxane-A2 modulate the response to tissue type plasminogen activator in vivo. Circulation Res 1989; 65: 83-94